Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Placebo Controlled Study of PH94B for Management of the Symptoms of Generalized Social Phobia

NCT01217788 is registered in ClinicalTrials.gov with Pherin Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01217788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01217788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Placebo Controlled Study of PH94B for Management of the Symptoms of Generalized Social Phobia
Lead sponsor
Pherin Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
March 31, 2011
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

social anxiety disorder, social phobia